STROMUSC Stanozolol(Winstrol)Oil Base For Bodybuilding CAS:10418-03-8

    What It Is: A UGL Innovation

    ●Core Compound: The active ingredient is Stanozolol (chemical name: 17β-hydroxy-17α-methyl-5α-androst-2-eno[3,2-c]pyrazole), a synthetic derivative of dihydrotestosterone (DHT). It possesses potent anabolic properties with relatively low androgenic effects compared to testosterone.

    ●The Oil Base Distinction: Unlike the official water-based suspension (which is gritty and requires frequent shaking), the "Oil Base" version is a solution or very fine suspension dissolved or suspended in a carrier oil (commonly sesame, grape seed, or MCT oil) using solvents like benzyl benzoate and benzyl alcohol. This is exclusively an Underground Lab (UGL) product. Pharmaceutical companies never produced an oil-based injectable Stanozolol due to its low solubility in oil and the existence of the oral and aqueous forms.

    ●Concentration: The "50mg" denotes 50 milligrams of Stanozolol per milliliter (ml) of solution/suspension. This high concentration is typical for UGL injectables aiming for reduced injection volume.

    ●Solubility Challenge: Stanozolol is notoriously difficult to dissolve in oil. Achieving a stable 50mg/ml concentration often requires significant amounts of solvents (BB/BA) or results in a very fine suspension rather than a true solution. This is the core technical challenge for UGLs.

    ●Appearance & Viscosity: Typically appears as a clear to slightly hazy, pale yellow to golden liquid. Viscosity depends on the carrier oil used (e.g., MCT is thinner than sesame oil).

    ●Reduced Injection Frequency (vs. Oral): While oral Winstrol requires daily dosing (often split), the injectable oil allows for administration every other day (EOD) or potentially less frequently, depending on the cycle and user goals.

    ●Avoidance of First-Pass Metabolism: Like all injectables, bypasses the liver on the first pass, potentially reducing liver strain compared to the oral version for the same total weekly dose. Crucially, Stanozolol is still C17-alpha alkylated (C17aa), making it hepatotoxic regardless of administration route.

    ●Potential for Reduced PIP (vs. Aqueous): The oil base is generally less irritating to muscle tissue than the gritty water-based suspension, potentially leading to less Post-Injection Pain (PIP). However, high solvent concentrations or impurities in UGL products can still cause significant PIP.

    ●Stability Concerns: Maintaining a stable solution/suspension at 50mg/ml in oil can be problematic. Crashes (precipitation of the hormone out of solution) are a known risk, especially with temperature fluctuations. Shaking vigorously before each draw is essential.

    ●UGL Variability: Quality, purity, actual concentration, sterility, and solvent levels vary drastically between UGL sources. This introduces significant risk and unpredictability.

    Oil-based Stanozolol-50mg is employed almost exclusively during specific phases:

    ●Contest Preparation (Cutting): This is its primary application. Bodybuilders use it in the final 6-8 weeks leading up to a competition. Its benefits align perfectly with cutting goals:

    ○Muscle Hardness & Density: Imparts a distinct "hard," grainy, and dense look to muscles, stripping away the final layer of water under the skin.

    ○Fat Loss Enhancement: While not a direct fat-burner, it helps preserve lean muscle mass in a severe calorie deficit, indirectly supporting fat loss by maintaining metabolic rate. Its slight nutrient partitioning effect may also be beneficial.

    ○Vascularity: Contributes significantly to increased vascularity, enhancing muscle definition.

    ○Strength Retention: Helps maintain strength during calorie restriction, aiding workout intensity.

    ●Performance Enhancement (Non-Competitive): Athletes in sports requiring speed, power, and strength-to-weight ratio (e.g., sprinting, wrestling) may use it off-season or pre-season for lean gains and performance without excessive bulk. Note: This is still doping and banned.

    ●"Recomp" Phases: Less common, but sometimes used in attempts to simultaneously lose fat and gain small amounts of lean muscle, though results are often subtle and diet/training dependent.

    ●Reduced Liver Stress (vs. Oral): Avoiding first-pass metabolism means less immediate stress on the liver per milligram administered. However, the hepatotoxicity remains significant due to the C17aa modification. Weekly liver strain might be similar or lower depending on total dose and frequency compared to daily high-dose orals.

    ●Stable Blood Levels (vs. Oral): Injections provide more stable blood levels than the peaks and troughs associated with oral dosing, potentially leading to more consistent effects and possibly reduced side effects related to fluctuations.

    ●Convenience (vs. Aqueous): Less frequent injections than daily oral dosing (though EOD is common). Less painful than water-based suspension injections (assuming good UGL quality).

    ●Avoidance of GI Issues: Some users experience stomach upset with oral Stanozolol; injectable bypasses this.

    ●Higher Dosing Potential (Theoretical): Some users believe the reduced first-pass allows for higher effective doses with less liver impact than achieving the same dose orally. This is debatable and risky.

    ●Dosage Range:

    ○Men: Typically 25mg to 50mg every other day (EOD). This equates to 75mg to 150mg per week. Doses exceeding 50mg EOD (150mg/week) significantly increase the risk of side effects with diminishing returns. Starting lower (e.g., 25mg EOD) is prudent.

    ○Women: Use is highly discouraged due to virilization risks (voice deepening, clitoral enlargement, facial hair). If used, doses are extremely low (e.g., 5-10mg EOD or less) for very short durations, but the risk remains high.

    ●Administration: Injected intramuscularly (IM) using standard aseptic techniques. Common sites include glutes, deltoids, quadriceps, and ventrogluteals. Due to the potential solvents and concentration, rotating injection sites is crucial to minimize scar tissue and PIP.

    ●Duration: Cycles rarely exceed 6-8 weeks due to significant hepatotoxicity. Using it longer drastically increases the risk of liver damage.

    Oil-based Stanozolol-50mg is almost never used alone (except potentially in very short pre-competition phases). It's a cutting/conditioning agent used alongside other compounds:

    ●Classic Cutting Stack:

    ○Base: Testosterone (Enanthate, Cypionate, or Propionate) at a TRT or slightly supra-physiological dose (e.g., 150-300mg/week). Provides essential androgen base, prevents low testosterone symptoms.

    ○Primary Cutter: Stanozolol Oil (e.g., 50mg EOD) - Weeks 1-6 or 1-8.

    ○Optional Additions:

    ◇Masteron (Drostanolone) for enhanced hardness/dryness (100-400mg/week).

    ◇Primobolan (Methenolone) for lean preservation with lower sides (400-600mg/week).

    ◇Anavar (Oxandrolone) for another mild oral cutter (dosed carefully due to liver strain).

    ◇Clenbuterol or Albuterol for thermogenic effects (cycled on/off).

    ●Crucial Considerations:

    ○Liver Protection: A high-quality liver support supplement (NAC, TUDCA, Milk Thistle) is mandatory throughout the cycle and during PCT.

    ○Cardiovascular Support: Monitor blood pressure. Use cardio support supplements (CoQ10, Hawthorne Berry, Omega-3s, potentially a low-dose ARB if BP rises).

    ○Lipids: Expect significant negative impact on HDL ("good") cholesterol. Increase healthy fats, fiber, and consider lipid-support supplements (Niacin, Citrus Bergamot, Fish Oil).

    ○Joints: Stanozolol can cause joint dryness/pain. Include joint support supplements (Glucosamine, Chondroitin, MSM, Cissus Quadrangularis) and ensure proper warm-ups.

    ●Stanozolol Half-Life: This is a key point of confusion. The half-life depends significantly on the route:

    ○Oral Stanozolol: Approximately 9 hours. Requires multiple daily doses (e.g., 2-3 times per day) for stable levels.

     ○Injectable Stanozolol (Aqueous or Oil Suspension): Approximately 24 hours. This is the critical figure for the oil-based UGL version. It's the ester that determines half-life for injectables. Stanozolol itself has no ester attached; it's the free steroid in suspension. Its half-life is dictated by the rate the crystals dissolve at the injection site and enter circulation.

    ●Implication for Dosing: The ~24-hour half-life necessitates injections at least every other day (EOD) to maintain reasonably stable blood levels. Daily injections would be more stable but are less common due to practicality and injection site tolerance.

    Despite its reputation as a "milder" steroid, Stanozolol suppresses the Hypothalamic-Pituitary-Testicular Axis (HPTA). PCT is absolutely essential after any cycle containing it to restore natural testosterone production.

    ●Timing: Begin PCT approximately 24-48 hours after the last Stanozolol injection (due to its 24hr half-life). If other longer-estered compounds (like Test Enanthate) were used in the stack, PCT must be timed based on the longest ester present (typically starting 14-18 days after last Test E/C injection).

    ●PCT Protocol (Example - 6-8 week Stanozolol + Test Cycle):

    ○Week 1-4: Clomiphene Citrate (Clomid) 50mg per day / Tamoxifen Citrate (Nolvadex) 20mg per day.

    ○Week 5-6: Clomid 25mg per day / Nolvadex 10mg per day.

(Durations and doses may vary based on cycle length, compounds used, and individual response)

    ●PCT Goals:

    ○Stimulate LH/FSH production to restart the testes.

    ○Restore natural testosterone levels.

    ○Prevent estrogen rebound (Nolvadex is key here).

    ○Preserve hard-earned muscle mass during the vulnerable post-cycle period.

    ●Continued Support: Continue liver support through PCT. Monitor lipids as they may take time to recover. Adequate calories (especially post-cut) and training are vital to retain muscle.

    ●Legality: Stanozolol is a Schedule III controlled substance in the US and illegal without a prescription in most countries. UGL products are unregulated and illegal.

    ●Health Risks: Significant risks include hepatotoxicity (liver damage), adverse lipid profile (increased LDL, decreased HDL), cardiovascular strain (increased blood pressure, potential left ventricular hypertrophy), joint pain, tendon weakness (increased injury risk), suppression of natural testosterone, virilization in women, acne, hair loss (in predisposed individuals), and potential for prostate issues.

    ●UGL Risks: Unverified contents (under-dosed, over-dosed, wrong compound, toxic impurities), bacterial contamination (abscess risk), high solvent content (increased PIP, potential nerve irritation), unstable solutions. Sterility is never guaranteed.

    ●Medical Supervision: Blood work (liver enzymes, lipids, CBC, hormones) before, during (mid-cycle), and after the cycle (pre-PCT and post-PCT) is non-negotiable for harm reduction. Consulting a physician aware of AAS use is ideal but often difficult.

Brand	STROMUSC
Trade names	Stanozolol, Stromba, Androstanazol; Androstanazole; Stanazol
CAS	10418-03-8
Molar mass	328.500
Formula	C21H32N2O
Purity	Above 98%
Capacity	50mg/ml,10ml/bottle

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-19128233885

   

                                

 

    Stanozolol-50mg Oil Base is a potent, UGL-specific adaptation of a classic steroid. Its primary appeal lies in providing the muscle-hardening, vascularity-enhancing, and lean-mass preserving effects of Stanozolol via an injectable route that potentially reduces first-pass liver stress and GI issues compared to the oral form, while offering a smoother injection experience than the aqueous suspension. The convenience of EOD dosing at a high concentration is a major factor in its popularity.

    However, it is unequivocally not a safer steroid. Its C17aa nature means significant hepatotoxicity remains. The cardiovascular and lipid risks are substantial. The reliance on unregulated UGL sources introduces massive variability and contamination risks. Its suppressive effects necessitate a robust PCT.

    Its application is highly specialized – primarily the final weeks of contest prep for experienced bodybuilders willing to accept the significant health and legal risks. For any non-competitive individual, the risks vastly outweigh the cosmetic benefits. Extreme caution, rigorous health monitoring, and a realistic understanding of the dangers are paramount for anyone considering its use.

Hot Tags: STROMUSC Stanozolol(Winstrol)Oil Base For Bodybuilding CAS:10418-03-8, China STROMUSC Stanozolol(Winstrol)Oil Base For Bodybuilding CAS:10418-03-8 manufacturers, suppliers, factory